ZTS - Zoetis Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $1.60
|
Rev Est: $2.3B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$141.17
DETAILS
HIGH:
$160.00
LOW:
$135.00
MEDIAN:
$138.00
CONSENSUS:
$141.17
UPSIDE:
9.72%
Market Cap:
56.70B
Volume:
3,610,341
Avg Volume:
5,228,781
52 Week Range:
115.25-177
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.96
Last Dividend:
$2.03
Exchange:
NYSE
Country:
US
Employees:
13,800
IPO Date:
2013-02-01
EPS (TTM):
6.03
P/E Ratio:
20.87
Revenue (TTM):
9.47B
Total Assets:
15.47B
Total Debt:
9.49B
Cash & Equiv:
2.31B
Rev Growth (5Y):
7.2%
EPS Growth (5Y):
11.9%
FCF Growth (5Y):
6.4%
ROCE:
27.1%
Debt/Equity:
2.85
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $1.48 | $1.40 | +5.7% | $2.4B | $2.4B | +1.1% |
| 2025-11-04 | $1.70 | $1.62 | +4.9% | $2.4B | $2.4B | -0.4% |
| 2025-08-05 | $1.76 | $1.62 | +8.6% | $2.5B | $2.4B | +2.1% |
| 2025-05-06 | $1.48 | $1.41 | +5.0% | $2.2B | $2.2B | +1.4% |
| 2025-02-13 | $1.40 | $1.37 | +2.2% | $2.3B | $2.3B | +0.9% |
| 2024-11-04 | $1.58 | $1.46 | +8.2% | $2.4B | $2.3B | +4.3% |
| 2024-08-06 | $1.56 | $1.49 | +4.7% | $2.4B | $2.3B | +2.1% |
| 2024-05-02 | $1.38 | $1.34 | +3.0% | $2.2B | $2.2B | +1.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.47B | 9.26B | 8.54B | 8.08B | 7.78B | 6.67B | 6.26B | 5.83B | 5.31B | 4.89B | 4.76B | 4.79B |
| Net Income | 2.67B | 2.49B | 2.34B | 2.11B | 2.04B | 1.64B | 1.50B | 1.43B | 864.00M | 821.00M | 339.00M | 583.00M |
| EPS | 6.03 | 5.47 | 5.08 | 4.51 | 4.29 | 3.44 | 3.14 | 2.96 | 1.76 | 1.66 | 0.68 | 1.16 |
| Total Assets | 15.47B | 14.24B | 14.29B | 14.93B | 13.90B | 13.61B | 11.54B | 10.78B | 8.59B | 7.65B | 7.91B | 6.59B |
| Total Debt | 9.49B | 6.74B | 6.75B | 8.09B | 6.74B | 7.36B | 6.61B | 6.45B | 4.95B | 4.47B | 4.87B | 3.63B |
| Cash & Equivalents | 2.31B | 1.99B | 2.04B | 3.58B | 3.48B | 3.60B | 1.93B | 1.60B | 1.56B | 727.00M | 1.15B | 882.00M |
| Operating Cash Flow | 2.90B | 2.95B | 2.35B | 1.91B | 2.21B | 2.13B | 1.79B | 1.79B | 1.35B | 713.00M | 664.00M | 626.00M |
| Free Cash Flow | 2.28B | 2.30B | 1.62B | 1.33B | 1.74B | 1.67B | 1.33B | 1.45B | 1.12B | 497.00M | 440.00M | 431.00M |
| FCF per Share | 5.15 | 5.06 | 3.51 | 2.83 | 3.66 | 3.52 | 2.79 | 3.01 | 2.29 | 1.00 | 0.88 | 0.86 |
| Book Value | 3.33B | 4.77B | 5.00B | 4.41B | 4.54B | 3.77B | 2.71B | 2.19B | 1.77B | 1.49B | 1.07B | 1.31B |
| Cash & ST Investments | 2.31B | 1.99B | 2.04B | 3.58B | 3.48B | 3.60B | 1.93B | 1.70B | 1.56B | 727.00M | 1.15B | 882.00M |
| ROC Equity | 0.80 | 0.52 | 0.47 | 0.48 | 0.45 | 0.43 | 0.55 | 0.65 | 0.49 | 0.55 | 0.32 | 0.44 |